Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Trial details
- Registry ID
- NCT00940225
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Cabometyx; Cabometyx®; XL-184; XL184
| No regulatory events match this view.This does not mean no FDA events have occurred. |